CONTEXT THERAPEUTICS INC. Earnings Per Share (Basic)
CONTEXT THERAPEUTICS INC. (CNTX) reported Earnings Per Share (Basic) of -$0.15 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- CONTEXT THERAPEUTICS INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.15.
- CONTEXT THERAPEUTICS INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.09.
- CONTEXT THERAPEUTICS INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.10.
- CONTEXT THERAPEUTICS INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.09.
- CONTEXT THERAPEUTICS INC. earnings per share, basic for fiscal 2025 was -$0.38.
- CONTEXT THERAPEUTICS INC. earnings per share, basic for fiscal 2024 was -$0.46.
- CONTEXT THERAPEUTICS INC. earnings per share, basic for fiscal 2023 was -$1.50.
- CONTEXT THERAPEUTICS INC. earnings per share, basic for fiscal 2022 was -$0.93.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.15 10-Q · filed 2026-08-05 | -$0.24 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | -$0.09 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | -$0.38 10-K · filed 2026-03-23 | |||
| 2025-09-30 | -$0.10 10-Q · filed 2025-11-05 | -$0.24 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | -$0.09 10-Q · filed 2026-08-05 | -$0.14 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | -$0.05 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | -$0.46 10-K · filed 2026-03-23 | |||
| 2024-09-30 | -$0.22 10-Q · filed 2025-11-05 | -$0.46 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | -$0.04 10-Q · filed 2025-08-06 | -$0.17 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | -$0.23 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | -$1.50 10-K · filed 2025-03-20 | |||
| 2023-09-30 | -$0.37 10-Q · filed 2024-11-06 | -$1.08 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | -$0.31 10-Q · filed 2024-08-07 | -$0.71 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$0.40 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$0.93 10-K · filed 2024-03-21 | |||
| 2022-09-30 | -$0.24 10-Q · filed 2023-11-09 | -$0.71 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | -$0.25 10-Q · filed 2023-08-09 | -$0.47 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | -$0.22 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | -$0.30 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$0.85 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$3.69 10-K · filed 2023-03-22 | |
| 2021-09-30 | -$4.00 10-Q · filed 2022-11-09 | -$20.74 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | -$14.18 10-Q · filed 2022-08-11 | -$16.82 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | -$2.55 10-Q · filed 2022-05-11 | |||
| 2020-12-31 | -$0.97 derived: net income ÷ weighted average shares · filed 2022-03-23 | -$3.48 derived: net income ÷ weighted average shares · filed 2022-03-23 | $3.07 10-K · filed 2022-03-23 | |
| 2020-09-30 | -$2.52 10-Q · filed 2021-12-02 | $4.04 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |